In this rapid insight episode, we look at the rise of weight-loss drugs. Don’t sleep on this theme, there may be some dramatic investment implications. Targeting obesity, these drugs are not just a healthcare game changer but may also have a profound economic impact on the estimated 3% of global GDP that obesity costs. Leading this transformation are companies like Novo Nordisk and Eli Lilly, which we look at in more detail in the podcast. Beyond healthcare, the influence of these drugs could extend to industries like fast food, gyms, luxury goods and health insurance. This pivotal development in healthcare reflects the evolving investment landscape, shaped by breakthrough medical advancements and their widespread implications.
Read the Blog Post here Watch the full episode here To listen in podcast form click here
Get an obligation-free portfolio recommendation to see how we would invest for you
Learn more about the hosts
Find us on social media:
Twitter
Instagram
Facebook
LinkedIn
Want to know more? Click here to Subscribe
Nucleus Wealth is an Australian Investment & Superannuation manager that can help you reach your financial goals through transparent, low-cost, ethically tailored portfolios. To find out more head to Nucleus Wealth Website.
The information on this podcast contains general information and does not take into account your personal objectives, financial situation or needs. Past performance is not an indication of future performance. Damien Klassen is an authorised representative of Nucleus Wealth Management. Nucleus Wealth is a business name of Nucleus Wealth Management Pty Ltd (ABN 54 614 386 266 ) and is a Corporate Authorised Representative of Nucleus Advice Pty Ltd - AFSL 515796
Responsible Investing DisclaimerNucleus Wealth offers all investors the option to tailor their investment portfolios according to the investor’s own brand of personal ethics. While Nucleus Wealth maintains ethical standards of integrity, honesty and reliability, it does not seek to impose these on its investors. Rather, Nucleus Wealth offers investors a system of investment that incorporates three core strategies: (i) customisable; (ii) transparent; and (iii) safe. Within this, investors are given the ability to customise their investments insofar as it aligns with their ethical preferences, rather than that of the fund manager, by using screens and tilts. Once the investor’s portfolio has been adjusted, Nucleus Wealth provides the investor with a company profile, access to performance dashboards and detailed monthly performance reports of each company within the investor’s portfolio to further inform the investor on their investment decision and the company’s ethical standing as it aligns with the screens and tilts opted for. Nucleus Wealth utilises a number of domestic and international sources to identify whether companies from particular countries or sectors fall within the categories of screens and tilts which the investor may choose to apply. While Nucleus Wealth undertakes its own fundamental analysis on each company, there is also the risk that investors could reach a different conclusion to Nucleus Wealth on whether a company falls within the frame of responsible filters being applied. For more information visit Nucleus Wealth's responsibility-related statements.
Ep.305 Rental Crisis: Effect On The Australian Economy | Nucleus Investment Insights
Ep. 304 Will Oil Fuel the Flames of Inflation? | Nucleus Investment Insights
6.43 AgrInvest: Sowing The Seeds For Future Profits | Nucleus Investment Insights
6.42 US Tech: The Magnificent Seven | Nucleus Investment Insights
Rapid Insights Ep.3: Hacked! Cybersecurity Stocks Fight Back
6.41 Hacked! An Investment Look at IT Security with Patrick Gray | Nucleus Investment Insights
6.40 Unlocking Hidden Opportunities: Thriving in Recession-Tested Sectors | Nucleus Investment Insights
28 The Shocking Truth About Retirement: How Planning Today Will Improve Your Tomorrow
6.39 Tightening The Screws On Aussie Households With Martin North | Nucleus Investment Insights
6.38 Income Extravaganza | Nucleus Investment Insights
6.37 Is The Chinese Snowball Getting Bigger? | Nucleus Investment Insights
6.36 Will US Commercial Property Be The Epicenter Of The Next Property Crash? | Nucleus Investment Insights
27 Super Strategies for a Stellar FY24 | Nucleus Wealth Empower
6.35 Jonathan Rochford: When A Distressed Debt Manager Meets An Economic Bust | Nucleus Investment Insights
6.34 Is The Iron Ore Trapdoor Opening? | Nucleus Investment Insights
6.33 PPI Crash: Unveiling Inflation's Future or Corporate Gouging? | Nucleus Investment Insights
26 GDP Unmasked: The Startling Truth Behind Your Daily Struggles | Nucleus Wealth Empower
6.32 Market Earnings At A Critical Point... Will Earnings Forecasts Hold Up? | Nucleus Investment Insights
6.31 Professor Steve Keen: Has Bank Lending Shuddered To A Halt? + Carbon Tracking | Nucleus Investment Insights
6.30 Michael West: On The Hunt For Abuse Of Power | Nucleus Investment Insights
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast